GC Biopharma Corp. (KRX:006280)
135,100
-2,100 (-1.53%)
Last updated: Dec 5, 2025, 11:06 AM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.55 trillion as of December 5, 2025. Its market cap has decreased by -12.19% in one year.
Market Cap
1.55T
Enterprise Value
2.69T
Revenue
1.93T
Ranking
n/a
PE Ratio
27.46
Stock Price
135,100.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.55T, an increase of 5,213.06%. That is a compound annual growth rate of 14.01%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |